Bivalirudin and Hypotension - a phase IV clinical study of FDA data

Summary:

Hypotension is reported as a side effect among people who take Bivalirudin (bivalirudin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Heparin, and have Percutaneous coronary intervention.

The phase IV clinical study analyzes which people have Hypotension when taking Bivalirudin. It is created by eHealthMe based on reports of 908 people who have side effects when taking Bivalirudin from the FDA, and is updated regularly.

What is Bivalirudin?

Bivalirudin has active ingredients of bivalirudin. eHealthMe is studying from 908 Bivalirudin users. Check the latest studies of Bivalirudin.

What is Hypotension?

Hypotension (abnormally low blood pressure) is found to be associated with 3,359 drugs and 4,756 conditions by eHealthMe. Check the latest studies of Hypotension.

On Jul, 17, 2026

908 people reported to have side effects when taking Bivalirudin.
Among them, 44 people (4.85%) have Hypotension.

Among these 44 people:

How long have people been on Bivalirudin when they have Hypotension? *

What is the gender of people who have Hypotension when taking Bivalirudin? *

female: 26.19 %
male: 73.81 %

What is the age of people who have Hypotension when taking Bivalirudin? *

What are other drugs people take besides Bivalirudin? *

What are other side effects people have besides Hypotension? *

Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 12 people, 27.27%
Heparin-Induced Thrombocytopenia: 12 people, 27.27%
Ventricular Fibrillation (abnormally irregular heart rhythm): 9 people, 20.45%
Acute Kidney Failure: 8 people, 18.18%
Chest Pain: 7 people, 15.91%
Cardiac Arrest: 7 people, 15.91%
Bradycardia (abnormally slow heart action): 7 people, 15.91%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 6 people, 13.64%
Multi-Organ Failure (multisystem organ failure): 6 people, 13.64%
Kounis Syndrome (the concurrence of heart pain with conditions associated with mast cell activation leads to heart muscle damage): 6 people, 13.64%

What are the existing conditions these people have? *

Percutaneous Coronary Intervention: 9 people, 20.45%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 4 people, 9.09%
Sedation: 4 people, 9.09%
Pain: 2 people, 4.55%
Venous Thrombosis Limb (blood clot that forms in a vein in the limb): 1 person, 2.27%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 2.27%
Cardiac Failure: 1 person, 2.27%
Cardiac Failure Chronic: 1 person, 2.27%
Cardiogenic Shock (inadequate circulation of blood): 1 person, 2.27%
Chest Pain: 1 person, 2.27%

* Approximation only. Some reports may have incomplete information.

Do you take Bivalirudin and have Hypotension?

- Check whether Hypotension is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bivalirudin:

Bivalirudin (908 reports)

Hypotension treatments and more:

Hypotension (329,856 reports)

Browse all side effects of Bivalirudin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypotension:

Hypotension (3,359 drugs)

Browse all the conditions that are associated with Hypotension:

Hypotension (4,756 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bivalirudin (the active ingredients of Bivalirudin) and Bivalirudin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.